Total Funding
54
30
Total FundingGrant raised
Growth Score 54 in past quarter
-4 pts
Heat Score 30 in past quarter
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
95886
ProVascTec is a preclinical stage cell treatment firm, to stimulate the development of a novel circulatory system.
About the Company
ProVascTec, a preclinical stage cell treatment firm, to stimulate the development of a novel circulatory system and form a natural bypass around arterial occlusions in the peripheral vascular system, particularly below the knee. The paracrine process of stem cells is used by ProVascTec, a preclinical stage cell treatment firm, to stimulate the
development of a novel circulatory system and form a natural bypass around arterial occlusions in the peripheral vascular system, particularly below the knee.